Knockdown of Myo-Inositol Transporter SMIT1 Normalizes Cholinergic and Glutamatergic Function in an Immortalized Cell Line Established from the Cerebral Cortex of a Trisomy 16 Fetal Mouse, an Animal Model of Human Trisomy 21 (Down Syndrome)

[1]  G. Jicha,et al.  1H-MRS metabolites in adults with Down syndrome: Effects of dementia , 2016, NeuroImage: Clinical.

[2]  B. Hille,et al.  Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels , 2016, Proceedings of the National Academy of Sciences.

[3]  M. Moran,et al.  Tyrosine phosphorylation of NEDD4 activates its ubiquitin ligase activity , 2014, Science Signaling.

[4]  R. Valabrègue,et al.  In vivo 1H MRS study in microlitre voxels in the hippocampus of a mouse model of Down syndrome at 11.7 T , 2014, NMR in biomedicine.

[5]  M. Toth,et al.  KCNQ1, KCNE2, and Na+-Coupled Solute Transporters Form Reciprocally Regulating Complexes That Affect Neuronal Excitability , 2014, Science Signaling.

[6]  F. Benfenati,et al.  Lithium rescues synaptic plasticity and memory in Down syndrome mice. , 2013, The Journal of clinical investigation.

[7]  Declan G. M. Murphy,et al.  Down syndrome with and without dementia: An in vivo proton Magnetic Resonance Spectroscopy study with implications for Alzheimer's disease , 2011, NeuroImage.

[8]  R. Popp,et al.  Activation of protein kinase C enhances NMDA-induced currents in primary cultured cerebellar granule cells: Effect of temperature and NMDA NR2 subunit composition. , 2008, European journal of pharmacology.

[9]  J. Segura-Aguilar,et al.  Effect of the knockdown of amyloid precursor protein on intracellular calcium increases in a neuronal cell line derived from the cerebral cortex of a trisomy 16 mouse , 2008, Experimental Neurology.

[10]  Lu Sun,et al.  Activation of extrasynaptic NMDA receptors induces a PKC‐dependent switch in AMPA receptor subtypes in mouse cerebellar stellate cells , 2007, The Journal of physiology.

[11]  C. Duarte,et al.  PKC Anchoring to GluR4 AMPA Receptor Subunit Modulates PKC‐Driven Receptor Phosphorylation and Surface Expression , 2007, Traffic.

[12]  J. Kew,et al.  Differential coupling of α7 and non‐α7 nicotinic acetylcholine receptors to calcium‐induced calcium release and voltage‐operated calcium channels in PC12 cells , 2007, Journal of neurochemistry.

[13]  Michelle de Saint Pierre,et al.  Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome , 2006, Journal of neuroscience research.

[14]  D. D. Allen,et al.  Neuronal dysfunction in Down syndrome: Contribution of neuronal models in cell culture , 2006, Journal of Physiology-Paris.

[15]  A. Simmons,et al.  Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. , 2005, Archives of general psychiatry.

[16]  T. Narahashi,et al.  Desensitization of nicotine acetylcholine receptors: modulation by kinase activation and phosphatase inhibition. , 2005, European journal of pharmacology.

[17]  James M. Eldred,et al.  The DNA sequence of human chromosome 7 , 2003, Nature.

[18]  C. Duarte,et al.  Protein Kinase Cγ Associates Directly with the GluR4 α-Amino-3-hydroxy-5-methyl-4-isoxazole Propionate Receptor Subunit , 2003, The Journal of Biological Chemistry.

[19]  Antonio G. García,et al.  Distinct protein kinases regulate SNAP‐25 expression in chromaffin cells , 2003, Journal of neuroscience research.

[20]  J. Barbara,et al.  IP3-dependent calcium-induced calcium release mediates bidirectional calcium waves in neurones: functional implications for synaptic plasticity. , 2002, Biochimica et biophysica acta.

[21]  Stephen K Fisher,et al.  Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance , 2002, Journal of neurochemistry.

[22]  S. Wonnacott,et al.  Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH‐SY5Y cells: contribution of voltage‐operated Ca2+ channels and Ca2+ stores , 2002, Journal of neurochemistry.

[23]  Kenzo Hirose,et al.  Visualization of IP3 Dynamics Reveals a Novel AMPA Receptor-Triggered IP3 Production Pathway Mediated by Voltage-Dependent Ca2+ Influx in Purkinje Cells , 2001, Neuron.

[24]  M. Bennett,et al.  Protein kinase C modulates NMDA receptor trafficking and gating , 2001, Nature Neuroscience.

[25]  E. Meyer,et al.  Involvement of α7 Nicotinic Acetylcholine Receptors in Activation of Tyrosine Hydroxylase and Dopamine β‐Hydroxylase Gene Expression in PC12 Cells , 2000 .

[26]  S. Rapoport,et al.  Impaired cholinergic function in cell lines derived from the cerebral cortex of normal and trisomy 16 mice , 2000, The European journal of neuroscience.

[27]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[28]  S. Rapoport,et al.  Ts65Dn Mouse, a Down Syndrome Model, Exhibits Elevated myo-Inositol in Selected Brain Regions and Peripheral Tissues , 2000, Neurochemical Research.

[29]  R. Peschka-Süss,et al.  Inhibition of inositol uptake in astrocytes by antisense oligonucleotides delivered by pH-sensitive liposomes. , 2000, European journal of biochemistry.

[30]  G. Berry,et al.  Murine chromosome 16 telomeric region, homologous with human chromosome 21q22, contains the osmoregulatory Na+/myo-inositol cotransporter (SLC5A3) gene , 2000, Cytogenetic and Genome Research.

[31]  S. Rapoport,et al.  Brain myo‐inositol level is elevated in Ts65Dn mouse and reduced after lithium treatment , 2000, Neuroreport.

[32]  G. Alexander,et al.  High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. , 1999, The American journal of psychiatry.

[33]  R. Zimmerman,et al.  In vivo brain myo-inositol levels in children with Down syndrome. , 1999, The Journal of pediatrics.

[34]  R. Lester,et al.  Regulation of α4β2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C , 1999 .

[35]  S. Rapoport,et al.  Calcium signals in cell lines derived from the cerebral cortex of normal and trisomy 16 mice. , 1999, Neuroreport.

[36]  W. Müller,et al.  Altered Ca2+ Signaling and Mitochondrial Deficiencies in Hippocampal Neurons of Trisomy 16 Mice: A Model of Down’s Syndrome , 1998, The Journal of Neuroscience.

[37]  C. Epstein,et al.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Rapoport,et al.  Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16. , 1997, Journal of mass spectrometry : JMS.

[39]  T. Shonk,et al.  Role of Increased Cerebral myo‐Inositol in the Dementia of Down Syndrome , 1995, Magnetic resonance in medicine.

[40]  N. Spinner,et al.  The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. , 1995, Genomics.

[41]  H. Nakayama,et al.  Phosphorylation of rat brain nicotinic acetylcholine receptor by cAMP-dependent protein kinase in vitro. , 1993, Brain research. Molecular brain research.

[42]  L. Role,et al.  Activators of protein kinase C enhance acetylcholine receptor desensitization in sympathetic ganglion neurons. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Meyer,et al.  Involvement of alpha7 nicotinic acetylcholine receptors in activation of tyrosine hydroxylase and dopamine beta-hydroxylase gene expression in PC12 cells. , 2000, Journal of neurochemistry.

[44]  R. Lester,et al.  Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C. , 1999, Molecular pharmacology.

[45]  H. Holloway,et al.  Brain accumulation of myo-inositol in the trisomy 16 mouse, an animal model of Down's syndrome. , 1996, The Biochemical journal.